@article{UBHD-68387936,
  author={Efficace, Fabio and Saußele, Susanne and Kossak-Roth, Ute},
  title={Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals?},
  subtitle={GIMEMA and EORTC Quality of Life Group},
  year={2012},
  pages={1371-1381},
  language={eng},
  issn={1432-0584},
  volume={91},
  number={9},
  note={Gesehen am 08.05.2019},
  journal={Annals of hematology},
  doi={10.1007/s00277-012-1458-6},
}
@article{UBHD-68380136,
  author={Kossak-Roth, Ute and Saußele, Susanne and Reiter, Andreas and Hehlmann, R{\"u}diger},
  title={Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leuk{\"a}mien (KNL)},
  year={2016},
  pages={444-453},
  language={ger},
  issn={1437-1588},
  volume={59},
  number={4},
  note={Gesehen am 11.04.2019},
  journal={Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz},
  doi={10.1007/s00103-016-2315-x},
}
@article{UBHD-68285317,
  author={Spiess, Birgit and Naumann, Nicole and Galuschek, Norbert and Rinaldetti, Sébastien and Kossak-Roth, Ute and Felde, Elena and Fabarius, Alice and Hofmann, Wolf-Karsten and Saußele, Susanne and Seifarth, Wolfgang},
  title={The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia},
  year={2018},
  pages={12 S.},
  language={eng},
  issn={1932-6203},
  volume={13(2018},
  note={Gesehen am 13.07.2018},
  journal={PLOS ONE},
  doi={10.1371/journal.pone.0196326},
  url={http://dx.doi.org/10.1371/journal.pone.0196326},
  library={UB},
}
@article{UBHD-68395117,
  author={Spiess, Birgit and Rinaldetti, Sébastien and Naumann, Nicole and Galuschek, Norbert and Kossak-Roth, Ute and Wuchter, Patrick and Tarnopolscaia, Irina and Rose, Diana and Voskanyan, Astghik and Fabarius, Alice and Hofmann, Wolf-Karsten and Saußele, Susanne and Seifarth, Wolfgang},
  title={Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials},
  year={2019},
  pages={15 S.},
  language={eng},
  issn={1932-6203},
  volume={14(2019},
  note={Gesehen am 04.06.2019},
  journal={PLOS ONE},
  doi={10.1371/journal.pone.0214305},
  url={https://doi.org/10.1371/journal.pone.0214305},
  library={UB},
}